Reports for LORAZEPAM

Ingredient

LORAZEPAM

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-LORAZEPAM 2MG TABLET Resolved 2020-08-12 2020-10-05 122071
APO-LORAZEPAM 2MG TABLET Resolved 2021-12-01 2021-12-20 150252
ATIVAN 0.5MG TABLET Resolved 2023-11-17 2024-06-26 210709
ATIVAN 0.5MG TABLET Resolved 2021-01-18 2021-04-13 131895
ATIVAN 0.5MG TABLET Anticipated shortage 2025-05-09 2025-05-09 256968
ATIVAN 0.5MG TABLET Resolved 2024-07-04 2024-11-26 232281
ATIVAN 1MG TABLET Resolved 2021-01-18 2021-03-26 131898
ATIVAN 2MG TABLET Resolved 2023-11-17 2024-10-03 210735
ATIVAN 1MG TABLET Resolved 2024-07-31 2024-08-08 234109
ATIVAN 1MG TABLET Resolved 2023-11-17 2024-07-04 210722

Showing 11 to 20 of 88

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
LORAZEPAM INJECTION USP 2MG SOLUTION Discontinued 2020-02-14 2020-03-12 106265
PMS-LORAZEPAM 0.5MG TABLET Discontinued 2020-06-15 2021-10-27 117717
PMS-LORAZEPAM 1MG TABLET Discontinued 2020-06-15 2021-10-27 117720

Showing 11 to 13 of 13